|
Volumn 65, Issue 1, 2002, Pages 56-60
|
Effect of the somatostatin analogue lanreotide on meal-stimulated portal blood flow in patients with liver cirrhosis
|
Author keywords
Doppler ultrasound; Humans; Lanreotide; Liver cirrhosis; Phase II clinical trial; Portal hypertension; Portal vein blood flow; Somatostatin analogues
|
Indexed keywords
ANGIOPEPTIN;
ENSURE;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
GASTROINTESTINAL AGENT;
SOMATOSTATIN;
ADULT;
AGED;
AREA UNDER THE CURVE;
ARTICLE;
BLOOD PRESSURE MEASUREMENT;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOPPLER FLOWMETRY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
FEMALE;
HEART RATE;
HUMAN;
LIVER CIRRHOSIS;
MALE;
MEAL;
MULTICENTER STUDY;
PERFUSION;
PORTAL HYPERTENSION;
PORTAL VEIN BLOOD FLOW;
POSTPRANDIAL STATE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ECHOGRAPHY;
FOOD;
MIDDLE AGED;
PATHOPHYSIOLOGY;
PHASE 2 CLINICAL TRIAL;
PORTAL VEIN;
DOUBLE-BLIND METHOD;
FEMALE;
FOOD;
GASTROINTESTINAL AGENTS;
HUMANS;
HYPERTENSION, PORTAL;
LIVER CIRRHOSIS;
MALE;
MIDDLE AGED;
PEPTIDES, CYCLIC;
PORTAL SYSTEM;
SOMATOSTATIN;
ULTRASONOGRAPHY, DOPPLER;
|
EID: 0036010670
PISSN: 00122823
EISSN: None
Source Type: Journal
DOI: 10.1159/000051932 Document Type: Article |
Times cited : (7)
|
References (20)
|